Breakthrough for type 1 diabetes funding
TYPE 1 diabetics have scored a crucial funding boost from the Federal Government after a $100 million announcement to expand free access to glucose monitoring devices.
The move is expected to save people in Flynn up to $7000 a year.
Access to glucose monitoring devices will be extended to pregnant women, children and more adults with the condition.
Type 1 diabetes is an autoimmune disease that attacks a person's ability to produce insulin. People with the condition must be able to monitor their glucose levels day and night.
Continuous glucose monitoring devices continually monitor a person's glucose levels and provide alerts if glucose levels drop too low.
Member for Flynn Ken O'Dowd welcomed the announcement from Health Minister Greg Hunt and said the investment guaranteed certainty.
"This additional funding over the next four years will ensure that free glucose monitoring devices will be available to over 37,000 eligible people with type 1 diabetes across Australia," Mr O'Dowd said.
"I had the pleasure of meeting with Gladstone resident Jaceen Ross, who travelled to Canberra on October 24 of this year.
"She gave me a real insight of what it is like for the eight per cent of people who are living in Flynn with type 1 diabetes."
Ms Ross said the battle for fully funded monitors was ongoing.
"It's now in Stage 2 so in 18 months to two years we've gone from no one being covered to pregnancy, concession holders with a clinical need and children with related conditions that require a CGM (continuous glucose monitors)," she said.
"It's very exciting because we're pushing through for CGM for all.
"The DANII Foundation helped push it over the line as well. But the fight is definitely not over."
The subsidies will become available on March 1 and include the following:
- Women with type 1 diabetes who are pregnant, breastfeeding or actively planning pregnancy,
- People with type 1 diabetes aged 21 years or older who have concessional status, and who have a high clinical need such as experiencing recurrent severe hypoglycaemic events,
- Children and young people with conditions similar to type 1 diabetes who require insulin. This includes a range of conditions such as cystic fibrosis related diabetes or neonatal diabetes.
The government also plans to add the new the FreeStyle Libre flash glucose monitoring system to the scheme for these people with type 1 diabetes.
This will provide patients with more choice in how they manage their diabetes through this important program.